The National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases play an important role in discovering innovative ways to address the growing diabetes epidemic in the United States, the American Diabetes Association said at a congressional briefing.
A drug made by Boehringer Ingelheim and Eli Lilly showed "meaningful and durable" reductions in blood sugar in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented Friday at a conference in Europe.
A report released Thursday by Bloomberg said that U.S. consumer confidence held last week at the second-lowest level of 2011 as the highest number of households in three years said it was a bad time to spend.
A diabetes drug made by Bristol-Myers Squibb and AstraZeneca significantly reduced Type 2 diabetes patients' blood-sugar levels, compared with placebo, when added to insulin, according to results of a new study.
Navarro Discount Pharmacy, a Hispanic-owned pharmacy chain and an MBF Healthcare portfolio company, has expanded its management team by naming Luis Mier as CFO and promoting Manuel Leon to VP wholesale and OTC programs.
Katz Group Canada, Canada’s largest integrated pharmacy network with more than 1,800 chain, franchise and independent pharmacies, has announced the retirement of industry veteran Andy Giancamilli as CEO, effective Feb. 2, 2012.
Walgreens on Friday spoke of the breadth of programs the chain has developed, many in partnership with Joslin Diabetes Center, to assist people with diabetes in living more healthily, at the 2011 Joslin Diabetes Roundtable held in Boston.
Clif Bar on Thursday will begin rewarding college students who follow the brand through social media with a Clif Bar Energy Pack that includes Clif Bar bars, fitness tips, water bottles and other items for outdoor recreation.